Showing results (71-80 of 177) with videos related to
Sort By:
Pageof 18
Patient Education and Counseling|June 18, 2010
Health literacy, numeracy, and interpretation of graphical breast cancer risk estimatesSandra M Brown, Julie O Culver, Kathryn E Osann, et al.JCO Precision Oncology|September 13, 2019
Patients' Medical and Psychosocial Experiences After Detection of a <i>CDH1</i> Variant With Multigene Panel TestingJada G Hamilton, Jessica M Long, Amanda C Brandt, et al.Cancer Cell|August 15, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.JNCI Cancer Spectrum|July 31, 2019
The Landscape of Somatic Genetic Alterations in Breast Cancers from <i>CHEK2</i> Germline Mutation CarriersDiana Mandelker, Rahul Kumar, Xin Pei, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancerChau T Dang, Gabriella M D'Andrea, Mary E Moynahan, et al.Journal of Genetic Counseling|October 17, 2022
Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriersDanielle B McKenna, Pauleen Sanchez, Jacquelyn Powers, et al.Cancer|March 7, 2012
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapyAlice Y Ho, Gaorav Gupta, Tari A King, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline <i>BRCA1/2</i> Mutations (ABRAZO)Nicholas C Turner, Melinda L Telli, Hope S Rugo, et al.Human Mutation|October 2, 2009
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantLili Li, Kajal Biswas, Laura Anne Habib, et al.NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.Pageof 18